 | • レポートコード：QAF27596 • 出版社/出版日：QYResearch / 2021年3月31日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のブルセラ症ワクチン市場について種類別（S19ワクチン、RB51ワクチン株、その他）、用途別（牛、羊、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ブルセラ症ワクチン市場の概要 ・世界の主要地域別ブルセラ症ワクチン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のブルセラ症ワクチン市場規模2016-2021：種類別（S19ワクチン、RB51ワクチン株、その他） ・世界のブルセラ症ワクチン市場予測2012-2027：種類別（S19ワクチン、RB51ワクチン株、その他） ・世界のブルセラ症ワクチン市場規模2016-2021：用途別（牛、羊、その他） ・世界のブルセラ症ワクチン市場予測2012-2027：用途別（牛、羊、その他） ・ブルセラ症ワクチンのアメリカ市場規模と予測2016-2021 ・ブルセラ症ワクチンのヨーロッパ市場規模と予測2016-2021 ・ブルセラ症ワクチンの中国市場規模と予測2016-2021 ・ブルセラ症ワクチンの日本市場規模と予測2016-2021 ・ブルセラ症ワクチンの東南アジア市場規模と予測2016-2021 ・ブルセラ症ワクチンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Jinyu、Colorado Serum、Boehringer Ingelheim、Biogenesis-Bago、Vetal Company、CZ Veterinaria、SYVA Laboratorios、Indian Immunologicals、Qilu、Tecnovax、Hester Biosciences、Zoetis、Onderstepoort Biological、Instituto Rosenbusch、Ceva Sante Animale、Calier & Biologicos Laverlam、Biovet） ・ブルセラ症ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ブルセラ症ワクチンの市場動向・機会・課題 ・調査の結論 |
Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.
The classification of Brucellosis Vaccines includes S19 Vaccine, RB51 Vaccine Strain and Other. And the proportion of S19 Vaccine in 2016 is about 86%, and the proportion is stable from 2012 to 2016.
Brucellosis Vaccines is widely used in Cattle, Sheep and Other Animal. The most proportion of Brucellosis Vaccines is for Cattle with market share about 60 in 2016.
Market Analysis and Insights: Global Brucellosis Vaccines Market
The global Brucellosis Vaccines market was valued at US$ 11 in 2020 and will reach US$ 13 million by the end of 2027, growing at a CAGR of 3.7% during 2022-2027.
Global Brucellosis Vaccines Scope and Market Size
The global Brucellosis Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Brucellosis Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
S19 Vaccine
RB51 Vaccine Strain
Others
Segment by Application
Cattle
Sheep
Others
The Brucellosis Vaccines market is analysed and market size information is provided by regions (countries). Segment by Application, the Brucellosis Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Jinyu
Colorado Serum
Boehringer Ingelheim
Biogenesis-Bago
Vetal Company
CZ Veterinaria
SYVA Laboratorios
Indian Immunologicals
Qilu
Tecnovax
Hester Biosciences
Zoetis
Onderstepoort Biological
Instituto Rosenbusch
Ceva Sante Animale
Calier & Biologicos Laverlam
Biovet
1 Brucellosis Vaccines Market Overview
1.1 Brucellosis Vaccines Product Scope
1.2 Brucellosis Vaccines Segment by Type
1.2.1 Global Brucellosis Vaccines Sales by Type (2016 & 2021 & 2027)
1.2.2 S19 Vaccine
1.2.3 RB51 Vaccine Strain
1.2.4 Others
1.3 Brucellosis Vaccines Segment by Application
1.3.1 Global Brucellosis Vaccines Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Cattle
1.3.3 Sheep
1.3.4 Others
1.4 Brucellosis Vaccines Market Estimates and Forecasts (2016-2027)
1.4.1 Global Brucellosis Vaccines Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Brucellosis Vaccines Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Brucellosis Vaccines Price Trends (2016-2027)
2 Brucellosis Vaccines Estimates and Forecasts by Region
2.1 Global Brucellosis Vaccines Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Brucellosis Vaccines Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Brucellosis Vaccines Sales Market Share by Region (2016-2021)
2.2.2 Global Brucellosis Vaccines Revenue Market Share by Region (2016-2021)
2.3 Global Brucellosis Vaccines Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Brucellosis Vaccines Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Brucellosis Vaccines Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Brucellosis Vaccines Estimates and Projections (2016-2027)
2.4.2 Europe Brucellosis Vaccines Estimates and Projections (2016-2027)
2.4.3 China Brucellosis Vaccines Estimates and Projections (2016-2027)
2.4.4 Japan Brucellosis Vaccines Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Brucellosis Vaccines Estimates and Projections (2016-2027)
2.4.6 India Brucellosis Vaccines Estimates and Projections (2016-2027)
3 Global Brucellosis Vaccines Competition Landscape by Players
3.1 Global Top Brucellosis Vaccines Players by Sales (2016-2021)
3.2 Global Top Brucellosis Vaccines Players by Revenue (2016-2021)
3.3 Global Brucellosis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Brucellosis Vaccines as of 2020)
3.4 Global Brucellosis Vaccines Average Price by Company (2016-2021)
3.5 Manufacturers Brucellosis Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Brucellosis Vaccines Market Size by Type
4.1 Global Brucellosis Vaccines Historic Market Review by Type (2016-2021)
4.1.1 Global Brucellosis Vaccines Sales Market Share by Type (2016-2021)
4.1.2 Global Brucellosis Vaccines Revenue Market Share by Type (2016-2021)
4.1.3 Global Brucellosis Vaccines Price by Type (2016-2021)
4.2 Global Brucellosis Vaccines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Brucellosis Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Brucellosis Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Global Brucellosis Vaccines Price Forecast by Type (2022-2027)
5 Global Brucellosis Vaccines Market Size by Application
5.1 Global Brucellosis Vaccines Historic Market Review by Application (2016-2021)
5.1.1 Global Brucellosis Vaccines Sales Market Share by Application (2016-2021)
5.1.2 Global Brucellosis Vaccines Revenue Market Share by Application (2016-2021)
5.1.3 Global Brucellosis Vaccines Price by Application (2016-2021)
5.2 Global Brucellosis Vaccines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Brucellosis Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Brucellosis Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Brucellosis Vaccines Price Forecast by Application (2022-2027)
6 North America Brucellosis Vaccines Market Facts & Figures
6.1 North America Brucellosis Vaccines Sales by Company
6.1.1 North America Brucellosis Vaccines Sales by Company (2016-2021)
6.1.2 North America Brucellosis Vaccines Revenue by Company (2016-2021)
6.2 North America Brucellosis Vaccines Sales Breakdown by Type
6.2.1 North America Brucellosis Vaccines Sales Breakdown by Type (2016-2021)
6.2.2 North America Brucellosis Vaccines Sales Breakdown by Type (2022-2027)
6.3 North America Brucellosis Vaccines Sales Breakdown by Application
6.3.1 North America Brucellosis Vaccines Sales Breakdown by Application (2016-2021)
6.3.2 North America Brucellosis Vaccines Sales Breakdown by Application (2022-2027)
7 Europe Brucellosis Vaccines Market Facts & Figures
7.1 Europe Brucellosis Vaccines Sales by Company
7.1.1 Europe Brucellosis Vaccines Sales by Company (2016-2021)
7.1.2 Europe Brucellosis Vaccines Revenue by Company (2016-2021)
7.2 Europe Brucellosis Vaccines Sales Breakdown by Type
7.2.1 Europe Brucellosis Vaccines Sales Breakdown by Type (2016-2021)
7.2.2 Europe Brucellosis Vaccines Sales Breakdown by Type (2022-2027)
7.3 Europe Brucellosis Vaccines Sales Breakdown by Application
7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)
8 China Brucellosis Vaccines Market Facts & Figures
8.1 China Brucellosis Vaccines Sales by Company
8.1.1 China Brucellosis Vaccines Sales by Company (2016-2021)
8.1.2 China Brucellosis Vaccines Revenue by Company (2016-2021)
8.2 China Brucellosis Vaccines Sales Breakdown by Type
8.2.1 China Brucellosis Vaccines Sales Breakdown by Type (2016-2021)
8.2.2 China Brucellosis Vaccines Sales Breakdown by Type (2022-2027)
8.3 China Brucellosis Vaccines Sales Breakdown by Application
8.3.1 China 318 Sales Breakdown by Application (2016-2021)
8.3.2 China 318 Sales Breakdown by Application (2022-2027)
9 Japan Brucellosis Vaccines Market Facts & Figures
9.1 Japan Brucellosis Vaccines Sales by Company
9.1.1 Japan Brucellosis Vaccines Sales by Company (2016-2021)
9.1.2 Japan Brucellosis Vaccines Revenue by Company (2016-2021)
9.2 Japan Brucellosis Vaccines Sales Breakdown by Type
9.2.1 Japan Brucellosis Vaccines Sales Breakdown by Type (2016-2021)
9.2.2 Japan Brucellosis Vaccines Sales Breakdown by Type (2022-2027)
9.3 Japan Brucellosis Vaccines Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Brucellosis Vaccines Market Facts & Figures
10.1 Southeast Asia Brucellosis Vaccines Sales by Company
10.1.1 Southeast Asia Brucellosis Vaccines Sales by Company (2016-2021)
10.1.2 Southeast Asia Brucellosis Vaccines Revenue by Company (2016-2021)
10.2 Southeast Asia Brucellosis Vaccines Sales Breakdown by Type
10.2.1 Southeast Asia Brucellosis Vaccines Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Brucellosis Vaccines Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Brucellosis Vaccines Sales Breakdown by Application
10.3.1 Southeast Asia M Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Doses Sales Breakdown by Application (2022-2027)
11 India Brucellosis Vaccines Market Facts & Figures
11.1 India Brucellosis Vaccines Sales by Company
11.1.1 India Brucellosis Vaccines Sales by Company (2016-2021)
11.1.2 India Brucellosis Vaccines Revenue by Company (2016-2021)
11.2 India Brucellosis Vaccines Sales Breakdown by Type
11.2.1 India Brucellosis Vaccines Sales Breakdown by Type (2016-2021)
11.2.2 India Brucellosis Vaccines Sales Breakdown by Type (2022-2027)
11.3 India Brucellosis Vaccines Sales Breakdown by Application
11.3.1 India Brucellosis Vaccines Sales Breakdown by Application (2016-2021)
11.3.2 India Brucellosis Vaccines Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Brucellosis Vaccines Business
12.1 Jinyu
12.1.1 Jinyu Corporation Information
12.1.2 Jinyu Business Overview
12.1.3 Jinyu Brucellosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Jinyu Brucellosis Vaccines Products Offered
12.1.5 Jinyu Recent Development
12.2 Colorado Serum
12.2.1 Colorado Serum Corporation Information
12.2.2 Colorado Serum Business Overview
12.2.3 Colorado Serum Brucellosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Colorado Serum Brucellosis Vaccines Products Offered
12.2.5 Colorado Serum Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Corporation Information
12.3.2 Boehringer Ingelheim Business Overview
12.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Boehringer Ingelheim Brucellosis Vaccines Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Biogenesis-Bago
12.4.1 Biogenesis-Bago Corporation Information
12.4.2 Biogenesis-Bago Business Overview
12.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Biogenesis-Bago Brucellosis Vaccines Products Offered
12.4.5 Biogenesis-Bago Recent Development
12.5 Vetal Company
12.5.1 Vetal Company Corporation Information
12.5.2 Vetal Company Business Overview
12.5.3 Vetal Company Brucellosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Vetal Company Brucellosis Vaccines Products Offered
12.5.5 Vetal Company Recent Development
12.6 CZ Veterinaria
12.6.1 CZ Veterinaria Corporation Information
12.6.2 CZ Veterinaria Business Overview
12.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 CZ Veterinaria Brucellosis Vaccines Products Offered
12.6.5 CZ Veterinaria Recent Development
12.7 SYVA Laboratorios
12.7.1 SYVA Laboratorios Corporation Information
12.7.2 SYVA Laboratorios Business Overview
12.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 SYVA Laboratorios Brucellosis Vaccines Products Offered
12.7.5 SYVA Laboratorios Recent Development
12.8 Indian Immunologicals
12.8.1 Indian Immunologicals Corporation Information
12.8.2 Indian Immunologicals Business Overview
12.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Indian Immunologicals Brucellosis Vaccines Products Offered
12.8.5 Indian Immunologicals Recent Development
12.9 Qilu
12.9.1 Qilu Corporation Information
12.9.2 Qilu Business Overview
12.9.3 Qilu Brucellosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Qilu Brucellosis Vaccines Products Offered
12.9.5 Qilu Recent Development
12.10 Tecnovax
12.10.1 Tecnovax Corporation Information
12.10.2 Tecnovax Business Overview
12.10.3 Tecnovax Brucellosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Tecnovax Brucellosis Vaccines Products Offered
12.10.5 Tecnovax Recent Development
12.11 Hester Biosciences
12.11.1 Hester Biosciences Corporation Information
12.11.2 Hester Biosciences Business Overview
12.11.3 Hester Biosciences Brucellosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Hester Biosciences Brucellosis Vaccines Products Offered
12.11.5 Hester Biosciences Recent Development
12.12 Zoetis
12.12.1 Zoetis Corporation Information
12.12.2 Zoetis Business Overview
12.12.3 Zoetis Brucellosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Zoetis Brucellosis Vaccines Products Offered
12.12.5 Zoetis Recent Development
12.13 Onderstepoort Biological
12.13.1 Onderstepoort Biological Corporation Information
12.13.2 Onderstepoort Biological Business Overview
12.13.3 Onderstepoort Biological Brucellosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Onderstepoort Biological Brucellosis Vaccines Products Offered
12.13.5 Onderstepoort Biological Recent Development
12.14 Instituto Rosenbusch
12.14.1 Instituto Rosenbusch Corporation Information
12.14.2 Instituto Rosenbusch Business Overview
12.14.3 Instituto Rosenbusch Brucellosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Instituto Rosenbusch Brucellosis Vaccines Products Offered
12.14.5 Instituto Rosenbusch Recent Development
12.15 Ceva Sante Animale
12.15.1 Ceva Sante Animale Corporation Information
12.15.2 Ceva Sante Animale Business Overview
12.15.3 Ceva Sante Animale Brucellosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Ceva Sante Animale Brucellosis Vaccines Products Offered
12.15.5 Ceva Sante Animale Recent Development
12.16 Calier & Biologicos Laverlam
12.16.1 Calier & Biologicos Laverlam Corporation Information
12.16.2 Calier & Biologicos Laverlam Business Overview
12.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Calier & Biologicos Laverlam Brucellosis Vaccines Products Offered
12.16.5 Calier & Biologicos Laverlam Recent Development
12.17 Biovet
12.17.1 Biovet Corporation Information
12.17.2 Biovet Business Overview
12.17.3 Biovet Brucellosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Biovet Brucellosis Vaccines Products Offered
12.17.5 Biovet Recent Development
13 Brucellosis Vaccines Manufacturing Cost Analysis
13.1 Brucellosis Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Brucellosis Vaccines
13.4 Brucellosis Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Brucellosis Vaccines Distributors List
14.3 Brucellosis Vaccines Customers
15 Market Dynamics
15.1 Brucellosis Vaccines Market Trends
15.2 Brucellosis Vaccines Drivers
15.3 Brucellosis Vaccines Market Challenges
15.4 Brucellosis Vaccines Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Brucellosis Vaccines Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Brucellosis Vaccines Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Brucellosis Vaccines Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Brucellosis Vaccines Sales (M Doses) by Region (2016-2021)
Table 5. Global Brucellosis Vaccines Sales Market Share by Region (2016-2021)
Table 6. Global Brucellosis Vaccines Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Brucellosis Vaccines Revenue Share by Region (2016-2021)
Table 8. Global Brucellosis Vaccines Sales (M Doses) Forecast by Region (2022-2027)
Table 9. Global Brucellosis Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Brucellosis Vaccines Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Brucellosis Vaccines Revenue Share Forecast by Region (2022-2027)
Table 12. Global Brucellosis Vaccines Sales (M Doses) of Key Companies (2016-2021)
Table 13. Global Brucellosis Vaccines Sales Share by Company (2016-2021)
Table 14. Global Brucellosis Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Brucellosis Vaccines Revenue Share by Company (2016-2021)
Table 16. Global Brucellosis Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brucellosis Vaccines as of 2020)
Table 17. Global Brucellosis Vaccines Average Price (USD/K Doses) of Key Company (2016-2021)
Table 18. Manufacturers Brucellosis Vaccines Manufacturing Sites and Area Served
Table 19. Manufacturers Brucellosis Vaccines Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Brucellosis Vaccines Sales (M Doses) by Type (2016-2021)
Table 22. Global Brucellosis Vaccines Sales Share by Type (2016-2021)
Table 23. Global Brucellosis Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Brucellosis Vaccines Price (USD/K Doses) by Type (2016-2021)
Table 25. Global Brucellosis Vaccines Sales Share by Type (2022-2027)
Table 26. Global Brucellosis Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Brucellosis Vaccines Revenue Share by Type (2022-2027)
Table 28. Global Brucellosis Vaccines Price (USD/K Doses) by Type (2022-2027)
Table 29. Global Brucellosis Vaccines Sales (M Doses) by Application (2016-2021)
Table 30. Global Brucellosis Vaccines Sales Share by Application (2016-2021)
Table 31. Global Brucellosis Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Brucellosis Vaccines Price (USD/K Doses) by Application (2016-2021)
Table 33. Global Brucellosis Vaccines Sales (M Doses) by Application (2022-2027)
Table 34. Global Brucellosis Vaccines Sales Share by Application (2022-2027)
Table 35. Global Brucellosis Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Brucellosis Vaccines Revenue Share by Application (2022-2027)
Table 37. Global Brucellosis Vaccines Price (USD/K Doses) by Application (2022-2027)
Table 38. North America Brucellosis Vaccines Sales (M Doses) by Company (2016-2021)
Table 39. North America Brucellosis Vaccines Sales Market Share by Company (2016-2021)
Table 40. North America Brucellosis Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Brucellosis Vaccines Revenue Market Share by Company (2016-2021)
Table 42. North America Brucellosis Vaccines Sales by Type (2016-2021) & (M Doses)
Table 43. North America Brucellosis Vaccines Sales Market Share by Type (2016-2021)
Table 44. North America Brucellosis Vaccines Sales by Type (2022-2027) & (M Doses)
Table 45. North America Brucellosis Vaccines Sales Market Share by Type (2022-2027)
Table 46. North America Brucellosis Vaccines Sales by Application (2016-2021) & (M Doses)
Table 47. North America Brucellosis Vaccines Sales Market Share by Application (2016-2021)
Table 48. North America Brucellosis Vaccines Sales by Application (2022-2027) & (M Doses)
Table 49. North America Brucellosis Vaccines Sales Market Share by Application (2022-2027)
Table 50. Europe Brucellosis Vaccines Sales (M Doses) by Company (2016-2021)
Table 51. Europe Brucellosis Vaccines Sales Market Share by Company (2016-2021)
Table 52. Europe Brucellosis Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Brucellosis Vaccines Revenue Market Share by Company (2016-2021)
Table 54. Europe Brucellosis Vaccines Sales by Type (2016-2021) & (M Doses)
Table 55. Europe Brucellosis Vaccines Sales Market Share by Type (2016-2021)
Table 56. Europe Brucellosis Vaccines Sales by Type (2022-2027) & (M Doses)
Table 57. Europe Brucellosis Vaccines Sales Market Share by Type (2022-2027)
Table 58. Europe Brucellosis Vaccines Sales by Application (2016-2021) & (M Doses)
Table 59. Europe Brucellosis Vaccines Sales Market Share by Application (2016-2021)
Table 60. Europe Brucellosis Vaccines Sales by Application (2022-2027) & (M Doses)
Table 61. Europe Brucellosis Vaccines Sales Market Share by Application (2022-2027)
Table 62. China Brucellosis Vaccines Sales (M Doses) by Company (2016-2021)
Table 63. China Brucellosis Vaccines Sales Market Share by Company (2016-2021)
Table 64. China Brucellosis Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Brucellosis Vaccines Revenue Market Share by Company (2016-2021)
Table 66. China Brucellosis Vaccines Sales by Type (2016-2021) & (M Doses)
Table 67. China Brucellosis Vaccines Sales Market Share by Type (2016-2021)
Table 68. China Brucellosis Vaccines Sales by Type (2022-2027) & (M Doses)
Table 69. China Brucellosis Vaccines Sales Market Share by Type (2022-2027)
Table 70. China Brucellosis Vaccines Sales by Application (2016-2021) & (M Doses)
Table 71. China Brucellosis Vaccines Sales Market Share by Application (2016-2021)
Table 72. China Brucellosis Vaccines Sales by Application (2022-2027) & (M Doses)
Table 73. China Brucellosis Vaccines Sales Market Share by Application (2022-2027)
Table 74. Japan Brucellosis Vaccines Sales (M Doses) by Company (2016-2021)
Table 75. Japan Brucellosis Vaccines Sales Market Share by Company (2016-2021)
Table 76. Japan Brucellosis Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Brucellosis Vaccines Revenue Market Share by Company (2016-2021)
Table 78. Japan Brucellosis Vaccines Sales by Type (2016-2021) & (M Doses)
Table 79. Japan Brucellosis Vaccines Sales Market Share by Type (2016-2021)
Table 80. Japan Brucellosis Vaccines Sales by Type (2022-2027) & (M Doses)
Table 81. Japan Brucellosis Vaccines Sales Market Share by Type (2022-2027)
Table 82. Japan Brucellosis Vaccines Sales by Application (2016-2021) & (M Doses)
Table 83. Japan Brucellosis Vaccines Sales Market Share by Application (2016-2021)
Table 84. Japan Brucellosis Vaccines Sales by Application (2022-2027) & (M Doses)
Table 85. Japan Brucellosis Vaccines Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Brucellosis Vaccines Sales (M Doses) by Company (2016-2021)
Table 87. Southeast Asia Brucellosis Vaccines Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Brucellosis Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Brucellosis Vaccines Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Brucellosis Vaccines Sales by Type (2016-2021) & (M Doses)
Table 91. Southeast Asia Brucellosis Vaccines Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Brucellosis Vaccines Sales by Type (2022-2027) & (M Doses)
Table 93. Southeast Asia Brucellosis Vaccines Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Brucellosis Vaccines Sales by Application (2016-2021) & (M Doses)
Table 95. Southeast Asia Brucellosis Vaccines Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Brucellosis Vaccines Sales by Application (2022-2027) & (M Doses)
Table 97. Southeast Asia Brucellosis Vaccines Sales Market Share by Application (2022-2027)
Table 98. India Brucellosis Vaccines Sales (M Doses) by Company (2016-2021)
Table 99. India Brucellosis Vaccines Sales Market Share by Company (2016-2021)
Table 100. India Brucellosis Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Brucellosis Vaccines Revenue Market Share by Company (2016-2021)
Table 102. India Brucellosis Vaccines Sales by Type (2016-2021) & (M Doses)
Table 103. India Brucellosis Vaccines Sales Market Share by Type (2016-2021)
Table 104. India Brucellosis Vaccines Sales by Type (2022-2027) & (M Doses)
Table 105. India Brucellosis Vaccines Sales Market Share by Type (2022-2027)
Table 106. India Brucellosis Vaccines Sales by Application (2016-2021) & (M Doses)
Table 107. India Brucellosis Vaccines Sales Market Share by Application (2016-2021)
Table 108. India Brucellosis Vaccines Sales by Application (2022-2027) & (M Doses)
Table 109. India Brucellosis Vaccines Sales Market Share by Application (2022-2027)
Table 110. Jinyu Corporation Information
Table 111. Jinyu Description and Business Overview
Table 112. Jinyu Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 113. Jinyu Brucellosis Vaccines Product
Table 114. Jinyu Recent Development
Table 115. Colorado Serum Corporation Information
Table 116. Colorado Serum Description and Business Overview
Table 117. Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 118. Colorado Serum Brucellosis Vaccines Product
Table 119. Colorado Serum Recent Development
Table 120. Boehringer Ingelheim Corporation Information
Table 121. Boehringer Ingelheim Description and Business Overview
Table 122. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 123. Boehringer Ingelheim Brucellosis Vaccines Product
Table 124. Boehringer Ingelheim Recent Development
Table 125. Biogenesis-Bago Corporation Information
Table 126. Biogenesis-Bago Description and Business Overview
Table 127. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 128. Biogenesis-Bago Brucellosis Vaccines Product
Table 129. Biogenesis-Bago Recent Development
Table 130. Vetal Company Corporation Information
Table 131. Vetal Company Description and Business Overview
Table 132. Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 133. Vetal Company Brucellosis Vaccines Product
Table 134. Vetal Company Recent Development
Table 135. CZ Veterinaria Corporation Information
Table 136. CZ Veterinaria Description and Business Overview
Table 137. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 138. CZ Veterinaria Brucellosis Vaccines Product
Table 139. CZ Veterinaria Recent Development
Table 140. SYVA Laboratorios Corporation Information
Table 141. SYVA Laboratorios Description and Business Overview
Table 142. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 143. SYVA Laboratorios Brucellosis Vaccines Product
Table 144. SYVA Laboratorios Recent Development
Table 145. Indian Immunologicals Corporation Information
Table 146. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 147. Indian Immunologicals Description and Business Overview
Table 148. Indian Immunologicals Brucellosis Vaccines Product
Table 149. Indian Immunologicals Recent Development
Table 150. Qilu Corporation Information
Table 151. Qilu Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 152. Qilu Description and Business Overview
Table 153. Qilu Brucellosis Vaccines Product
Table 154. Qilu Recent Development
Table 155. Tecnovax Corporation Information
Table 156. Tecnovax Description and Business Overview
Table 157. Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 158. Tecnovax Brucellosis Vaccines Product
Table 159. Tecnovax Recent Development
Table 160. Hester Biosciences Corporation Information
Table 161. Hester Biosciences Description and Business Overview
Table 162. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 163. Hester Biosciences Brucellosis Vaccines Product
Table 164. Hester Biosciences Recent Development
Table 165. Zoetis Corporation Information
Table 166. Zoetis Description and Business Overview
Table 167. Zoetis Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 168. Zoetis Brucellosis Vaccines Product
Table 169. Zoetis Recent Development
Table 170. Onderstepoort Biological Corporation Information
Table 171. Onderstepoort Biological Description and Business Overview
Table 172. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 173. Onderstepoort Biological Brucellosis Vaccines Product
Table 174. Onderstepoort Biological Recent Development
Table 175. Instituto Rosenbusch Corporation Information
Table 176. Instituto Rosenbusch Description and Business Overview
Table 177. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 178. Instituto Rosenbusch Brucellosis Vaccines Product
Table 179. Instituto Rosenbusch Recent Development
Table 180. Ceva Sante Animale Corporation Information
Table 181. Ceva Sante Animale Description and Business Overview
Table 182. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 183. Ceva Sante Animale Brucellosis Vaccines Product
Table 184. Ceva Sante Animale Recent Development
Table 185. Calier & Biologicos Laverlam Corporation Information
Table 186. Calier & Biologicos Laverlam Description and Business Overview
Table 187. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 188. Calier & Biologicos Laverlam Brucellosis Vaccines Product
Table 189. Calier & Biologicos Laverlam Recent Development
Table 190. Biovet Corporation Information
Table 191. Biovet Description and Business Overview
Table 192. Biovet Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 193. Biovet Brucellosis Vaccines Product
Table 194. Biovet Recent Development
Table 195. Production Base and Market Concentration Rate of Raw Material
Table 196. Key Suppliers of Raw Materials
Table 197. Brucellosis Vaccines Distributors List
Table 198. Brucellosis Vaccines Customers List
Table 199. Brucellosis Vaccines Market Trends
Table 200. Brucellosis Vaccines Market Drivers
Table 201. Brucellosis Vaccines Market Challenges
Table 202. Brucellosis Vaccines Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Brucellosis Vaccines Product Picture
Figure 2. Global Brucellosis Vaccines Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Brucellosis Vaccines Sales Market Share by Application in 2021 & 2027
Figure 6. Cattle Examples
Figure 7. Sheep Examples
Figure 8. Others Examples
Figure 9. Global Brucellosis Vaccines Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Brucellosis Vaccines Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Brucellosis Vaccines Sales (M Doses) Growth Rate (2016-2027)
Figure 12. Global Brucellosis Vaccines Price Trends Growth Rate (2016-2027) (USD/K Doses)
Figure 13. Global Brucellosis Vaccines Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Brucellosis Vaccines Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Brucellosis Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Brucellosis Vaccines Sales (M Doses) Growth Rate (2016-2027)
Figure 17. Europe Brucellosis Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Brucellosis Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Brucellosis Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Brucellosis Vaccines Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Brucellosis Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Brucellosis Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Brucellosis Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Brucellosis Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Brucellosis Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Brucellosis Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Brucellosis Vaccines Players Market Share by Revenue in Brucellosis Vaccines: 2016 & 2020
Figure 28. Brucellosis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Brucellosis Vaccines Revenue Share by Type (2016-2021)
Figure 30. Global Brucellosis Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Brucellosis Vaccines Revenue Share by Application (2016-2021)
Figure 32. Global Brucellosis Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Brucellosis Vaccines Sales Market Share by Type in 2020
Figure 34. North America Brucellosis Vaccines Sales Market Share by Application in 2020
Figure 35. Europe Brucellosis Vaccines Sales Market Share by Type in 2020
Figure 36. Europe Brucellosis Vaccines Sales Market Share by Application in 2020
Figure 37. China Brucellosis Vaccines Sales Market Share by Type in 2020
Figure 38. China Brucellosis Vaccines Sales Market Share by Application in 2020
Figure 39. Japan Brucellosis Vaccines Sales Market Share by Type in 2020
Figure 40. Japan Brucellosis Vaccines Sales Market Share by Application in 2020
Figure 41. Southeast Asia Brucellosis Vaccines Sales Market Share by Type in 2020
Figure 42. Southeast Asia Brucellosis Vaccines Sales Market Share by Application in 2020
Figure 43. India Brucellosis Vaccines Sales Market Share by Type in 2020
Figure 44. India Brucellosis Vaccines Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Brucellosis Vaccines
Figure 47. Manufacturing Process Analysis of Brucellosis Vaccines
Figure 48. Brucellosis Vaccines Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
世界の牛用呼吸器ワクチン市場規模・現状・予測（2021年-2027年） Bovine respiratory vaccines for the prevention of respiratory diseases in cattle such as Infectious Bovine Rhinotracheitis (IBR), Bovine Viral Diarrhea (BVD), Parainfluenza 3 (PI3) and Bovine Respiratory Syncytial Virus (BRSV). A variety of vaccines are available. See product details for vaccine use…- 世界の牛用ワクチン市場規模・現状・予測（2021年-2027年） One of the most common questions in cow/calf production is what vaccines are necessary on an annual basis to keep the herd healthy. Market Analysis and Insights: Global Cattle Vaccines Market The global Cattle Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in …
- 旅行者用ワクチンのグローバル市場2021 A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates …
- 世界のヒトDNAワクチン市場規模・現状・予測（2021年-2027年） DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet to become a competitive alternative to conventional protein or carbohydrate based human vaccines. Whilst safety concerns were an initial barrier, the Achilles heel of DNA vaccines remains their poor immunoge…
- DNAワクチンのグローバル市場2021 The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines. N…